Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
0.2910
-0.0340 (-10.46%)
At close: Jun 27, 2025, 4:00 PM
0.3079
+0.0169 (5.81%)
After-hours: Jun 27, 2025, 7:50 PM EDT
Mersana Therapeutics Market Cap
Mersana Therapeutics has a market cap or net worth of $36.27 million as of June 27, 2025. Its market cap has decreased by -86.88% in one year.
Market Cap
36.27M
Enterprise Value
-41.40M
1-Year Change
-86.88%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since June 28, 2017, Mersana Therapeutics's market cap has decreased from $317.00M to $36.27M, a decrease of -88.56%. That is a compound annual growth rate of -23.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 36.30M | -79.46% |
| Dec 31, 2024 | 176.70M | -36.85% |
| Dec 29, 2023 | 279.80M | -52.15% |
| Dec 30, 2022 | 584.70M | 30.72% |
| Dec 31, 2021 | 447.30M | -75.46% |
| Dec 31, 2020 | 1.82B | 564.25% |
| Dec 31, 2019 | 274.40M | 190.06% |
| Dec 31, 2018 | 94.60M | -74.69% |
| Dec 29, 2017 | 373.80M | 17.92% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| Novo Nordisk | 331.06B |
| AbbVie | 322.03B |
| UnitedHealth Group | 280.41B |
| Abbott Laboratories | 233.80B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |